Clinical Trials in Miami

Showing 3681-3700 of 5,521 trials

Immunogenicity of PCV-7 Vaccine in VLBW Infants

NCT00273325

Premature infants are at a high risk for pneumonia. The PCV-7 vaccine effectively prevents the invasive disease from Streptococcus pneumoniae in full-term infants, but was not thoroughly studied in premature infants. This study evaluated the effectiveness and safety of the vaccine given in routine practice to very low birth weight infants, looking at blood antibody levels 4-6 weeks after the final vaccine dose, and adverse events, survival, infections, and neurodevelopmental outcomes at 18-22 months corrected age.

Pneumococcal InfectionsStreptococcus PneumoniaeInfant, Newborn+3 more

NICHD Neonatal Research Network368 participantsStarted Jul 2004

Birmingham, Alabama, United States • Palo Alto, California, United States • Miami, Florida, United States +7 more locations

COMPLETEDPhase 2/3< 1 mile

Exosurf Neonatal and Survanta for Treatment of Respiratory Distress Syndrome

NCT01203358

The purpose of this study is to compare the efficacy of two surfactants, Exosurf Neonatal (Burroughs Wellcome Co.) and Survanta (Ross Laboratories), for the treatment of neonatal respiratory distress syndrome.

Infant, NewbornInfant, Low Birth WeightInfant, Small for Gestational Age+2 more

NICHD Neonatal Research Network617 participantsStarted Jan 1991

Palo Alto, California, United States • New Haven, Connecticut, United States • Washington D.C., District of Columbia, United States +10 more locations

Immunogenicity of PCV-7 Vaccine in VLBW Infants

Exosurf Neonatal and Survanta for Treatment of Respiratory Distress Syndrome

Find Trials by Condition in Miami

Early Diagnosis of Candidiasis in Premature Infants

Persistent Pulmonary Hypertension of the Newborn (PPHN) Observational Study

Use of the VisuMax™ Femtosecond Laser

Omadacycline Versus Linezolid for the Treatment of ABSSSI (EudraCT #2013-003644-23)

Phase IIIb Study of APD421 in Combination as PONV Prophylaxis

Efficacy, Safety, and Tolerability of Oral Ubrogepant in the Acute Treatment of Migraine

UltraShape Power for Abdominal Fat and Circumference Reduction

An Open-label Study to Evaluate the Long-term Safety and Tolerability of LUM001 in Patients With Primary Biliary Cirrhosis

Safety and Efficacy of Preoperative Antithrombin Supplementation in Patients Undergoing High-Risk Cardiopulmonary Bypass

Study to Evaluate Efficacy of CO-1.01 as Second Line Therapy for Gemcitabine-Refractory Stage IV Pancreatic Adenocarcinoma

A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c

ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab

A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy

Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination

Dating Matters: Strategies to Promote Healthy Teen Relationships

A Multicenter, Open-Label Study To Investigate The Safety And Pharmacokinetics Of Lacosamide In Children With Partial Seizures

PRET: Patients Prone to Recurrence After Endovascular Treatment

Open-Label Study of Asfotase Alfa in Infants and Children ≤ 5 Years of Age With Hypophosphatasia (HPP)